Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Disclosure statements are available on the authors' profiles:
Weight regain and cardiometabolic effects after withdrawal of semaglutide: the STEP 1 trial extensionDiabetes Obes Metab 2022 Apr 19;[EPub Ahead of Print], JP Wilding, RL Batterham, M Davies, LFV Gaal, K Kandler, K Konakli, I Lingvay, BM McGowan, T Kalayci Oral, J Rosenstock, TA Wadden, S Wharton, K Yokote, RF Kushner
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.